Danaparoid Sodium Reduces Inflammation and Lung Injury in Rats
Author Information
Author(s): Hagiwara Satoshi, Iwasaka Hideo, Hidaka Seigo, Hishiyama Sohei, Noguchi Takayuki
Primary Institution: Oita University Faculty of Medicine
Hypothesis
Danaparoid sodium would act as an inhibitor of systemic inflammation and prevent endotoxin-induced acute lung injury in a rat model.
Conclusion
Danaparoid sodium decreases cytokine and HMGB1 levels during inflammation, improving lung pathology and reducing mortality in a rat model.
Supporting Evidence
- Survival was significantly higher in the danaparoid sodium-treated group compared to the control group.
- Danaparoid sodium treatment led to lower levels of inflammatory cytokines in serum and lung tissue.
- Histopathological analysis showed improved lung tissue condition in the danaparoid sodium group.
Takeaway
This study shows that a medicine called danaparoid sodium can help sick rats by reducing inflammation in their lungs and helping them survive better.
Methodology
Male Wistar rats were treated with danaparoid sodium or saline after lipopolysaccharide administration, and various cytokine levels were measured over time.
Limitations
The mechanisms of action of danaparoid sodium in this model are not fully understood.
Participant Demographics
Male Wistar rats weighing 250 to 300 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website